Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Toshiyuki, Imagumbai"'
Autor:
Shogo Shinohara, Shinji Takebayashi, Kiyomi Hamaguchi, Tetsuhiko Michida, Yota Tobe, Tadashi Ikenaga, Mami Yasumoto, Ayami Hamamoto, Toshiyuki Imagumbai, Takamasa Mitsuyoshi, Ryo Ashida, Takahiro Iwai, Shun Okabayashi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 15 (2021)
Background: Concurrent chemoradiotherapy (CCRT) with tri-weekly high-dose cisplatin (HDC) is considered the standard regimen. However, due to significant toxicity, various weekly low-dose schedules have been increasingly used. We investigated the tol
Externí odkaz:
https://doaj.org/article/7c652ffcb8b1419ca2c4bc602d5702e7
Autor:
Takamasa Mitsuyoshi, Yuka Ono, Ryo Ashida, Mikiko Yamashita, Hiroaki Tanabe, Sayaka Takebe, Mariko Tokiwa, Eiji Suzuki, Toshiyuki Imagumbai, Michio Yoshimura, Chikako Yamauchi, Takashi Mizowaki, Masaki Kokubo
Publikováno v:
Japanese Journal of Clinical Oncology. 53:174-178
Purpose The UK-FAST-Forward study showed that ultra-hypofractionated whole-breast irradiation (ultra-HF-WBI) involving five fractions of 26 Gy radiation over 1 week was not inferior to HF-WBI. However, it is not used in Japan due to safety concerns.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a705e1ba5fea2886684cfa6d30f35276
https://doi.org/10.1093/jjco/hyac174
https://doi.org/10.1093/jjco/hyac174
Autor:
Takahiro Iwai, Toshiyuki Imagumbai, Shun Okabayashi, Ryo Ashida, Takamasa Mitsuyoshi, Yukimasa Tai, Toshihiko Matsumoto, Daisuke Yamashita, Tohru Nagano, Masaki Kokubo
Publikováno v:
International Cancer Conference Journal. 12:41-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0e73b220be977f6082b26f924b76538
https://doi.org/10.1007/s13691-022-00574-7
https://doi.org/10.1007/s13691-022-00574-7
Autor:
Takahiro Iwai, Toshiyuki Imagumbai, Shinya Hiraoka, Takahiro Kishi, Shun Okabayashi, Ryo Ashida, Takamasa Mitsuyoshi, Yukinori Matsuo, Takashi Ishigaki, Takashi Mizowaki, Masaki Kokubo
Background: Combined modality therapy, including radiotherapy (RT), is a common treatment for scalp or face angiosarcoma. Although intensity-modulated radiotherapy (IMRT) can deliver homogeneous doses to the scalp or face, the clinical data are limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab4495b06125e4a1f14557eab8cff077
https://doi.org/10.21203/rs.3.rs-2927948/v1
https://doi.org/10.21203/rs.3.rs-2927948/v1
Autor:
Yoshiko Doi, Yasushi Nagata, Yasuo Matsumoto, Kazushi Numata, Ryu Sasaki, Takashi Yamada, Hiroshi Igaki, Toshiyuki Imagumbai, Norio Katoh, Tadamasa Yoshitake, Takuya Shimizuguchi, Den Fujioka, Minoru Inoue, Yutaro Koide, Tomoki Kimura, Yoshinori Ito
Publikováno v:
Hepatology Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::910006f7ed2ab294850674364c1aa1ea
https://doi.org/10.1111/hepr.13908
https://doi.org/10.1111/hepr.13908
Autor:
Hideyuki, Harada, Shota, Omori, Keita, Mori, Masahiro, Konno, Haruyasu, Murakami, Toshiyuki, Imagumbai, Haruyuki, Fukuda, Kiyoshi, Nakamatsu, Tomoki, Kimura, Hiroaki, Tanabe, Hideki, Fujita, Hitoshi, Tatebe, Kazunori, Fujitaka, Yasumasa, Nishimura
Publikováno v:
International Journal of Clinical Oncology. 27:1025-1033
This multi-institutional clinical trial evaluated the feasibility of intensity-modulated radiotherapy (IMRT) for patients with locally advanced non-small cell lung cancer (NSCLC).The major inclusion criteria were clinical stage III NSCLC, age 20-74 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9345c2976531b59241a59adc4f92c0
https://doi.org/10.1007/s10147-022-02151-7
https://doi.org/10.1007/s10147-022-02151-7
Autor:
Yukihisa Tamaki, Norihiro Aibe, Takafumi Komiyama, Satoshi Nagasaka, Toshiyuki Imagumbai, Tomoko Itazawa, Hiroshi Onishi, Tetsuo Akimoto, Yasushi Nagata, Yuko Nakayama
Publikováno v:
Cancers. 14(9)
A crucial issue in radical radiation therapy for non-small-cell lung cancer is how to define the clinical target volume (CTV). Although the scope of microscopic extension (ME) and microscopic proximal bronchial extension (PBE) from a primary tumor sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae76d8061325d64a3773a121f1da487f
https://pubmed.ncbi.nlm.nih.gov/35565447
https://pubmed.ncbi.nlm.nih.gov/35565447
Autor:
Takamasa Mitsuyoshi, Tadashi Ikenaga, Shogo Shinohara, Mami Yasumoto, Yota Tobe, Ayami Hamamoto, Takahiro Iwai, Toshiyuki Imagumbai, Ryo Ashida, Shun Okabayashi, Tetsuhiko Michida, Shinji Takebayashi, Kiyomi Hamaguchi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 15 (2021)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights. Oncology
Background: Concurrent chemoradiotherapy (CCRT) with tri-weekly high-dose cisplatin (HDC) is considered the standard regimen. However, due to significant toxicity, various weekly low-dose schedules have been increasingly used. We investigated the tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373b695b7d3e3a5818f87fe1222bb22b
https://doi.org/10.1177/11795549211048417
https://doi.org/10.1177/11795549211048417
Autor:
Hitoshi Araki, Toshiyuki Imagumbai, Atsushi Komaru, Kazuo Hatano, Takeshi Ueda, Satoshi Fukasawa, Takeshi Namekawa, Ryusuke Hara, Masayuki Kobayashi, Tomohiko Ichikawa
Publikováno v:
International Journal of Urology. 22:477-482
Objectives To investigate the therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate- and high-risk prostate cancer. Methods This was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::580dd73543e1c97518dc977a79b30ffb
https://doi.org/10.1111/iju.12707
https://doi.org/10.1111/iju.12707
Autor:
Toshiyuki Imagumbai, Taketo Yamaguchi, Mitsuhiro Sakai, Takeshi Ishihara, Taro Hara, Hitoshi Araki, Kentaro Sudo, Osamu Yokosuka, Hisao Ito, Tadamichi Denda, Kazuo Hatano, Kazuyoshi Nakamura, Hiroyuki Kawakami, Katsunobu Tawada, Takashi Uno
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 80:119-125
Purpose S-1 is an oral fluoropyrimidine derivative that has demonstrated favorable antitumor activity in patients with metastatic pancreatic cancer. The aim of this study was to evaluate safety and efficacy of S-1 and concurrent radiotherapy in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794275a129facf3ebf83fab911efb124
https://doi.org/10.1016/j.ijrobp.2010.01.027
https://doi.org/10.1016/j.ijrobp.2010.01.027